Cancer Treatment and Research Communications

Código QR

Cancer Treatment and Research Communications

Guardado en:

Detalles Bibliográficos
Formato:	journal
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	cancer biology molecular carcinogenesis genetics and genomics stem cells developmental biology oncology Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/toc/2468-2942
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Fusobacterium nucleatum and oral cancer: a critical review
por: Emily McIlvanna, et al.
Publicado: (2021)

Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets
por: Jiangnan He, et al.
Publicado: (2021)

A common goal to CARE: Cancer Advocates, Researchers, and Clinicians Explore current treatments and clinical trials for breast cancer brain metastases
por: Natalie S. Joe, et al.
Publicado: (2021)

A randomized intervention involving family to improve communication in breast cancer care
por: Jennifer L. Wolff, et al.
Publicado: (2021)

FUBP1 promotes colorectal cancer stemness and metastasis via DVL1‐mediated activation of Wnt/β‐catenin signaling
por: Haofan Yin, et al.
Publicado: (2021)

Breast cancer in Brazil: epidemiology and treatment challenges
por: Cecilio AP, et al.
Publicado: (2015)

Exercise after breast cancer treatment: current perspectives
por: Dieli-Conwright CM, et al.
Publicado: (2015)

Effectiveness of maintenance treatments for nonsmall cell lung cancer
por: Eadens MJ, et al.
Publicado: (2011)

Profile of neratinib and its potential in the treatment of breast cancer
por: Feldinger K, et al.
Publicado: (2015)

Cardiac risk in the treatment of breast cancer: assessment and management
por: Valachis A, et al.
Publicado: (2015)

Targeting stem cells in the realm of drug-resistant breast cancer
por: Dey P, et al.
Publicado: (2019)

Afatinib treatment in advanced non-small cell lung cancer
por: Hurwitz JL, et al.
Publicado: (2011)

Challenges in the development of future treatments for breast cancer stem cells
por: Shyam A Patel, et al.
Publicado: (2010)

Role of pertuzumab in the treatment of HER2-positive breast cancer
por: Hubalek M, et al.
Publicado: (2012)

Breast cancer causes and treatment: where are we going wrong?
por: Seymour CB, et al.
Publicado: (2013)

New developments in the treatment of HER2-positive breast cancer
por: Nahta R
Publicado: (2012)

Molecular Profiling of Endometrial Cancer: An Exploratory Study in Aotearoa, New Zealand
por: Claire E. Henry, et al.
Publicado: (2021)

The Role of Whole Exome Sequencing in Distinguishing Primary and Secondary Lung Cancers
por: Vokes NI, et al.
Publicado: (2021)

Management of early breast cancer in older women: from screening to treatment
por: Elomrani F, et al.
Publicado: (2015)

Preserving fertility in patients undergoing treatment for breast cancer: current perspectives
por: Moffat R, et al.
Publicado: (2014)

Emerging treatment options in the management of non-small cell lung cancer
por: Filosso PL, et al.
Publicado: (2011)

Clinical evidence of the efficacy of everolimus and its potential in the treatment of breast cancer
por: Saksena R, et al.
Publicado: (2013)

Palbociclib: an evidence-based review of its potential in the treatment of breast cancer
por: Cadoo KA, et al.
Publicado: (2014)

Role of trastuzumab emtansine in the treatment of HER2-positive breast cancer
por: Oostra DR, et al.
Publicado: (2014)

Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond
por: Suda K, et al.
Publicado: (2013)

Potential of afatinib in the treatment of patients with HER2-positive breast cancer
por: Geuna E, et al.
Publicado: (2012)

The expanding role of pertuzumab in the treatment of HER2-positive breast cancer
por: Moya-Horno I, et al.
Publicado: (2015)

Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
por: G. Emerens Wensink, et al.
Publicado: (2021)

Treatment scheduling effects on the evolution of drug resistance in heterogeneous cancer cell populations
por: Gauri A. Patwardhan, et al.
Publicado: (2021)

Emerging treatments in lung cancer – targeting the RLIP76 molecular transporter
por: Goldfinger LE, et al.
Publicado: (2013)

Aromatase inhibitors in the treatment of breast cancer in post-menopausal female patients: an update
por: Schneider RE, et al.
Publicado: (2011)

Profile of bavituximab and its potential in the treatment of non-small-cell lung cancer
por: Stasi I, et al.
Publicado: (2014)

Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer
por: Hurvitz SA, et al.
Publicado: (2012)

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
por: Criscitiello C, et al.
Publicado: (2018)

Profile of ceritinib in the treatment of ALK+ metastatic non-small-cell lung cancer
por: Burns MW, et al.
Publicado: (2015)

Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism
por: Alessia Lodi, et al.
Publicado: (2017)

First-line treatment of advanced ALK-positive non-small-cell lung cancer
por: Gandhi S, et al.
Publicado: (2015)

Trastuzumab emtansine in the treatment of HER2-positive metastatic breast cancer in Japanese patients
por: Sawaki M
Publicado: (2014)

Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer
por: Minami S, et al.
Publicado: (2015)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma
por: Amaia Lujambio, et al.
Publicado: (2021)